276 related articles for article (PubMed ID: 16940444)
1. The effects of growth hormone treatment on bone mineral density and body composition in girls with turner syndrome.
Ari M; Bakalov VK; Hill S; Bondy CA
J Clin Endocrinol Metab; 2006 Nov; 91(11):4302-5. PubMed ID: 16940444
[TBL] [Abstract][Full Text] [Related]
2. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
[TBL] [Abstract][Full Text] [Related]
3. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial.
Sass TC; De Muinck Keizer-Schrama SM; Stijnen T; Asarfi A; Van Leeuwen WJ; Van Teunenbroek A; Van Rijn RR; Drop SL
Clin Endocrinol (Oxf); 2000 May; 52(5):531-6. PubMed ID: 10792330
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
Lem AJ; van der Kaay DC; Hokken-Koelega AC
J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
[TBL] [Abstract][Full Text] [Related]
6. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Massa GG; Rouwe CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 1999 Dec; 84(12):4607-12. PubMed ID: 10599727
[TBL] [Abstract][Full Text] [Related]
7. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; van Leeuwen WJ; Asarfi A; van Rijn RR; Drop SL;
Pediatr Res; 2001 Sep; 50(3):417-22. PubMed ID: 11518831
[TBL] [Abstract][Full Text] [Related]
9. Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome.
Wooten N; Bakalov VK; Hill S; Bondy CA
J Clin Endocrinol Metab; 2008 Jun; 93(6):2109-14. PubMed ID: 18349057
[TBL] [Abstract][Full Text] [Related]
10. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.
Zeger MP; Shah K; Kowal K; Cutler GB; Kushner H; Ross JL
Horm Res Paediatr; 2011; 75(1):38-46. PubMed ID: 20733274
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of body composition and bone in patients with juvenile idiopathic arthritis treated with growth hormone.
Bechtold S; Ripperger P; Dalla Pozza R; Roth J; Häfner R; Michels H; Schwarz HP
J Clin Endocrinol Metab; 2010 Jan; 95(1):178-85. PubMed ID: 19880788
[TBL] [Abstract][Full Text] [Related]
12. Impact of Growth Hormone on Adult Bone Quality in Turner Syndrome: A HR-pQCT Study.
Nour MA; Burt LA; Perry RJ; Stephure DK; Hanley DA; Boyd SK
Calcif Tissue Int; 2016 Jan; 98(1):49-59. PubMed ID: 26439721
[TBL] [Abstract][Full Text] [Related]
13. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone treatment and aortic dimensions in Turner syndrome.
Bondy CA; Van PL; Bakalov VK; Ho VB
J Clin Endocrinol Metab; 2006 May; 91(5):1785-8. PubMed ID: 16507631
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
Menke LA; Sas TC; de Muinck Keizer-Schrama SM; Zandwijken GR; de Ridder MA; Odink RJ; Jansen M; Delemarre-van de Waal HA; Stokvis-Brantsma WH; Waelkens JJ; Westerlaken C; Reeser HM; van Trotsenburg AS; Gevers EF; van Buuren S; Dejonckere PH; Hokken-Koelega AC; Otten BJ; Wit JM
J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
[TBL] [Abstract][Full Text] [Related]
16. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency.
Boot AM; Engels MA; Boerma GJ; Krenning EP; De Muinck Keizer-Schrama SM
J Clin Endocrinol Metab; 1997 Aug; 82(8):2423-8. PubMed ID: 9253311
[TBL] [Abstract][Full Text] [Related]
17. Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study.
Nabhan ZM; Dimeglio LA; Qi R; Perkins SM; Eugster EA
J Clin Endocrinol Metab; 2009 Jun; 94(6):2009-14. PubMed ID: 19318455
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment.
Boot AM; Nauta J; de Jong MC; Groothoff JW; Lilien MR; van Wijk JA; Kist-van Holthe JE; Hokken-Koelega AC; Pols HA; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 1998 Nov; 49(5):665-72. PubMed ID: 10197084
[TBL] [Abstract][Full Text] [Related]
20. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.
Biller BM; Sesmilo G; Baum HB; Hayden D; Schoenfeld D; Klibanski A
J Clin Endocrinol Metab; 2000 Mar; 85(3):970-6. PubMed ID: 10720025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
